BioNTech SE (BNTX) Prepaid Assets (2018 - 2019)
BioNTech SE's (BNTX) quarterly Prepaid Assets came in at $388517.6 in Q4 2019, up 119.61% year-on-year from $176916.4 in Q4 2018, and up 119.61% quarter-over-quarter from $176916.4 in Q4 2018.
BioNTech SE (BNTX) Prepaid Assets (2018 - 2019) Analysis & Trends
BioNTech SE has disclosed Prepaid Assets across 2 years of filings, most recently posting $388517.6 for Q4 2019.
- Prepaid Assets for Q4 2019 came in at $388517.6, up 119.61% year-over-year; the trailing twelve-month figure through Dec 2019 was $388517.6 (up 119.61% YoY), and the FY2019 annual result was $388517.6, up 112.18% from the prior year.
- Prepaid Assets came in at $388517.6 for Q4 2019 at BioNTech SE, up from $176916.4 in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $388517.6 in Q4 2019 to a low of $176916.4 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | BioNTech SE | 27.38 Bn | 10.07 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 388,517.57 |
| Dec 31, 2018 | 176,916.45 |